Nitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signaling.

Nitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signaling.
复制标题

DOI:
10.1371/journal.pone.0001313
复制
发表时间:
2007-12-12
期刊:
影响因子:
3.7
通讯作者:
Lindner DJ
Lindner DJ
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Bauer JA;Lupica JA;Szugye H;Morrison BH;Haney RM;Masci RK;Lee RM;Didonato JA;Lindner DJ

文献摘要

参考文献

被引文献

相似文献

Nitrosylcobalamin (NO-Cbl) is a chemotherapeutic pro-drug derived from vitamin B12 that preferentially delivers nitric oxide (NO) to tumor cells, based upon increased receptor expression. NO-Cbl induces Apo2L/TRAIL-mediated apoptosis and inhibits survival signaling in a variety of malignant cell lines. Chemotherapeutic agents often simultaneously induce an apoptotic signal and activation of NF-κB, which has the undesired effect of promoting cell survival. The specific aims of this study were to 1) measure the anti-tumor effects of NO-Cbl alone and in combination with conventional chemotherapeutic agents, and to 2) examine the mechanism of action of NO-Cbl as a single agent and in combination therapy. Using anti-proliferative assays, electrophoretic mobility shift assay (EMSA), immunoblot analysis and kinase assays, we demonstrate an increase in the effectiveness of chemotherapeutic agents in combination with NO-Cbl as a result of suppressed NF-κB activation. Eighteen chemotherapeutic agents were tested in combination with NO-Cbl, in thirteen malignant cell lines, resulting in a synergistic anti-proliferative effect in 78% of the combinations tested. NO-Cbl pre-treatment resulted in decreased NF-κB DNA binding activity, inhibition of IκB kinase (IKK) enzymatic activity, decreased AKT activation, increased caspase-8 and PARP cleavage, and decreased cellular XIAP protein levels. The use of NO-Cbl to inhibit survival signaling may enhance drug efficacy by preventing concomitant activation of NF-κB or AKT.
DOI: 10.1002/ijc.2910030518
发表时间: 1968-01-01
影响因子: 6.4
作者:
FLODH, H;ULLBERG, S
通讯作者: ULLBERG, S
DOI: 10.1093/emboj/17.17.5170
发表时间: 1998-09-01
期刊: EMBO JOURNAL
影响因子: 11.4
作者:
Bender, K;Göttlicher, M;Herrlich, P
通讯作者: Herrlich, P
DOI: 10.1074/jbc.m306111200
发表时间: 2003-10-10
影响因子: 4.8
作者:
Chawla-Sarkar, M;Bauer, JA;Lindner, DJ
通讯作者: Lindner, DJ
DOI: 10.1016/s0962-8924(00)01729-3
发表时间: 2000-04-01
影响因子: 19
作者:
Israël, A
通讯作者: Israël, A
DOI: 10.1172/jci11991
发表时间: 2001-02-01
影响因子: 15.9
作者:
Baldwin, AS
通讯作者: Baldwin, AS